ArticleJournal of ovarian research2026

Impact of adverse events-associated dose modifications of PARP inhibitors on treatment outcomes in primary ovarian cancer.

Yue Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.